Zhang Y - Search Results

1

Results of low-dose computed tomography as a regular health examination among Chinese hospital employees.

Zhang Y, Jheon S, Li H, Zhang H, Xie Y, Qian B, Lin K, Wang S, Fu C, Hu H, Zheng Y, Li Y, Chen H. Zhang Y, et al. Among authors: zhang h. J Thorac Cardiovasc Surg. 2020 Sep;160(3):824-831.e4. doi: 10.1016/j.jtcvs.2019.10.145. Epub 2019 Nov 14. J Thorac Cardiovasc Surg. 2020. PMID: 31987625 Free article.

2

Neoadjuvant or adjuvant chemotherapy for non-small-cell lung cancer: Does the timing matter?

Zhang Y, Chen H. Zhang Y, et al. J Thorac Cardiovasc Surg. 2019 Feb;157(2):756-757. doi: 10.1016/j.jtcvs.2018.10.006. Epub 2018 Oct 12. J Thorac Cardiovasc Surg. 2019. PMID: 30470540 Free article. No abstract available.

3

Segment Location and Ground Glass Opacity Ratio Reliably Predict Node-Negative Status in Lung Cancer.

Zhang Y, Fu F, Wen Z, Deng L, Wang S, Li Y, Chen H. Zhang Y, et al. Ann Thorac Surg. 2020 Apr;109(4):1061-1068. doi: 10.1016/j.athoracsur.2019.10.072. Epub 2019 Dec 18. Ann Thorac Surg. 2020. PMID: 31863756

4

Commentary: Challenges to thoracic surgeons in the global coronavirus pandemic.

Zhang Y, Chen H. Zhang Y, et al. J Thorac Cardiovasc Surg. 2020 Aug;160(2):593-594. doi: 10.1016/j.jtcvs.2020.04.004. Epub 2020 Apr 10. J Thorac Cardiovasc Surg. 2020. PMID: 32331818 Free PMC article. No abstract available.

5

Gefitinib as neoadjuvant therapy for resectable stage II-IIIA non-small cell lung cancer: A phase II study.

Zhang Y, Fu F, Hu H, Wang S, Li Y, Hu H, Chen H. Zhang Y, et al. J Thorac Cardiovasc Surg. 2021 Feb;161(2):434-442.e2. doi: 10.1016/j.jtcvs.2020.02.131. Epub 2020 Mar 19. J Thorac Cardiovasc Surg. 2021. PMID: 32340810 Free article. Clinical Trial.

6

Management of Ground-Glass Opacities in the Lung Cancer Spectrum.

Zhang Y, Fu F, Chen H. Zhang Y, et al. Ann Thorac Surg. 2020 Dec;110(6):1796-1804. doi: 10.1016/j.athoracsur.2020.04.094. Epub 2020 Jun 7. Ann Thorac Surg. 2020. PMID: 32525031 Review.

7

Computed tomography density is not associated with pathological tumor invasion for pure ground-glass nodules.

Fu F, Zhang Y, Wang S, Li Y, Wang Z, Hu H, Chen H. Fu F, et al. Among authors: zhang y. J Thorac Cardiovasc Surg. 2021 Aug;162(2):451-459.e3. doi: 10.1016/j.jtcvs.2020.04.169. Epub 2020 May 28. J Thorac Cardiovasc Surg. 2021. PMID: 32711984 Free article.

8

Commentary: Nonadherence to guidelines: It is important to investigate the reasons and survival outcomes.

Zhang Y, Chen H. Zhang Y, et al. J Thorac Cardiovasc Surg. 2021 Sep;162(3):662-663. doi: 10.1016/j.jtcvs.2020.05.056. Epub 2020 May 31. J Thorac Cardiovasc Surg. 2021. PMID: 32718699 Free article. No abstract available.

9

Ground Glass Opacity-Predominant Lung Cancer Is Independently Associated With Node Negative Status: Reply.

Zhang Y, Chen H. Zhang Y, et al. Ann Thorac Surg. 2021 Apr;111(4):1406-1407. doi: 10.1016/j.athoracsur.2020.06.042. Epub 2020 Aug 22. Ann Thorac Surg. 2021. PMID: 32835756 No abstract available.

10

Commentary: Is sublobar resection enough for ground-glass opacity-dominant lung adenocarcinoma?

Zhang Y, Chen H. Zhang Y, et al. J Thorac Cardiovasc Surg. 2022 Jan;163(1):303-304. doi: 10.1016/j.jtcvs.2020.09.126. Epub 2020 Oct 8. J Thorac Cardiovasc Surg. 2022. PMID: 33158561 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

259,840 results

Search Page

Filters